CD59 antibody

Catalog No. ABIN2191998

Product Details anti-CD59 Antibody

Target: CD59

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This CD59 antibody is un-conjugated

Application: Flow Cytometry (FACS), Western Blotting (WB), Immunoprecipitation (IP), Blocking Antibody (Inhibition)

Sterility: 0.2 μm filtered

Endotoxin Level: Low endotoxin level

Clone: MEM-43

Application Details

Application Notes: For flow cytometry and Western blotting dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:10. For neutralization of biological activity dilutions have to be made according to the amounts endotoxin to be inactivated.

Restrictions: For Research Use only

Handling

Buffer: PBS and 0.1 % bovine serum albumin with low endotoxin level.

Storage: 4 °C

Storage Comment: Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.

Expiry Date: 12 months

References for anti-CD59 antibody (ABIN2191998)

Yamamoto, Nakane, Doi, Osaki: "Lipopolysaccharide signal transduction in oral keratinocytes--involvement of CD59 but not CD14." in: Cellular signalling, Vol. 15, Issue 9, pp. 861-9, (2003) (PubMed).

Target Details for CD59

Target: CD59

Alternative Name: CD59 (CD59 Products)

Background: The antibody is the prototypic antibody for the CD59 determinant, a PI-linked glycoprotein of 18-25 kDa, which is broadly expressed on most types of cells. The antigen is the major complement-protecting molecule of human cells. It is expressed on all leukocytes, erythrocytes and most other cell types. Binding of this antibody inhibits the complement-protecting activity of CD59. CD59 is one of the complement regulatory membrane proteins that is missing in Paroxysmal Nocturnal Haemoglobinuria (PNH). Anti CD59 reagents may be useful in the differential diagnosis of PNH type II and PNH type I. Recently a role for CD59 in LPS signal transduction has been reported in keratinocytes. The antibody reacts with well defined epitope (W40, R-53) on CD59 Molecule.

Pathways: Complement System